Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $110.52-$157.97 |
Market Cap | $12.7B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $2.2B |
Revenue Growth (YoY) | 24.7% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | $3.74 |
News
See moreYahoo Finance • last month
Exploring Three High Growth Tech Stocks in the United States
Yahoo Finance • 2 months ago
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Yahoo Finance • 3 months ago
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
Yahoo Finance • 3 months ago
Insider Sale: Director William Rastetter Sells 14,250 Shares of Neurocrine Biosciences Inc (NBIX)
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 12780 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,700 |
